ReviewCells2026

Mechanistic and Clinical Differences Between Daratumumab and Isatuximab in Multiple Myeloma: Emerging Roles of 1q Gain and Immune Remodeling.

Jiro Kikuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.